ANAHEIM, CA — Switching to clopidogrel postdischarge after starting on a more potent P2Y12 inhibitor as part of dual antiplatelet therapy (DAPT) after primary PCI apparently doesn't lead to a greater ...
ROME, Italy—The choice of prasugrel or ticagrelor for patients with acute MI undergoing primary PCI may make little difference, at least in the short term, suggest results from the PRAGUE-18 trial. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results